HK1101131A1 - Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients - Google Patents
Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patientsInfo
- Publication number
- HK1101131A1 HK1101131A1 HK07109167.1A HK07109167A HK1101131A1 HK 1101131 A1 HK1101131 A1 HK 1101131A1 HK 07109167 A HK07109167 A HK 07109167A HK 1101131 A1 HK1101131 A1 HK 1101131A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fragments
- bcl
- family
- cancer patients
- proteins belonging
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 102000051485 Bcl-2 family Human genes 0.000 title abstract 2
- 108700038897 Bcl-2 family Proteins 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title abstract 2
- 102000007079 Peptide Fragments Human genes 0.000 abstract 2
- 108010033276 Peptide Fragments Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52311903P | 2003-11-19 | 2003-11-19 | |
| DKPA200301716 | 2003-11-19 | ||
| PCT/DK2004/000799 WO2005049073A2 (en) | 2003-11-19 | 2004-11-18 | Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1101131A1 true HK1101131A1 (en) | 2007-10-12 |
Family
ID=39149116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07109167.1A HK1101131A1 (en) | 2003-11-19 | 2007-08-23 | Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7842294B2 (xx) |
| EP (2) | EP2087904B1 (xx) |
| JP (2) | JP4926714B2 (xx) |
| KR (2) | KR101284237B1 (xx) |
| CN (1) | CN1921878B (xx) |
| AT (1) | ATE424842T1 (xx) |
| AU (1) | AU2004290866B2 (xx) |
| CA (1) | CA2546794C (xx) |
| DE (1) | DE602004019965D1 (xx) |
| DK (2) | DK1691824T3 (xx) |
| ES (2) | ES2323588T3 (xx) |
| HK (1) | HK1101131A1 (xx) |
| MX (1) | MXPA06005738A (xx) |
| PL (2) | PL2087904T3 (xx) |
| PT (1) | PT1691824E (xx) |
| RU (1) | RU2367468C2 (xx) |
| WO (1) | WO2005049073A2 (xx) |
| ZA (1) | ZA200604866B (xx) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7892559B2 (en) | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| ES2529203T3 (es) * | 2003-01-30 | 2015-02-17 | Survac Aps | Péptidos derivados de survivina y uso de los mismos |
| US20130052215A9 (en) | 2003-09-26 | 2013-02-28 | Eckhard Podack | Tumor vaccine |
| WO2006034334A2 (en) | 2004-09-21 | 2006-03-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| EP1820229A4 (en) * | 2004-10-19 | 2011-06-08 | Massachusetts Inst Technology | VIRUS FRAME FOR A SELF-CONSTRUCTED FLEXIBLE AND LIGHT LITHIUM BATTERY |
| CN101111260B (zh) * | 2005-02-04 | 2013-03-20 | 萨瓦克公司 | 存活蛋白肽疫苗 |
| AU2011203535B2 (en) * | 2005-02-04 | 2012-10-11 | Survac Aps | Survivin peptide vaccine |
| EP1934250A2 (en) * | 2005-09-09 | 2008-06-25 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Methods and compositions for inhibiting cell death or enhancing cell proliferation |
| WO2008116468A2 (en) * | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
| EP3620465A1 (en) | 2007-07-03 | 2020-03-11 | Dako Denmark A/S | Improved methods for generation, labeling and use of mhc multimers |
| EP2197908A2 (en) * | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| WO2009106073A2 (en) * | 2008-02-28 | 2009-09-03 | Dako Denmark A/S | Mhc multimers in borrelia diagnostics and disease |
| US10968269B1 (en) | 2008-02-28 | 2021-04-06 | Agilent Technologies, Inc. | MHC multimers in borrelia diagnostics and disease |
| AU2009246876B2 (en) | 2008-05-16 | 2015-04-02 | Taiga Biotechnologies, Inc. | Antibodies and processes for preparing the same |
| EP2313516A4 (en) * | 2008-07-16 | 2012-04-04 | Burnham Inst Medical Research | COMPOSITIONS AND METHODS FOR MODULATING THE NOD LIKE RECEPTOR ACTIVITY AND THEIR USE |
| WO2010009735A2 (en) | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Combinatorial analysis and repair |
| DK2966084T3 (en) | 2008-08-28 | 2018-08-06 | Taiga Biotechnologies Inc | MODULATORS OF MYC, PROCEDURES FOR USING SAME AND PROCEDURES FOR IDENTIFYING SUBSTANCES MODULATING MYC |
| GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
| WO2010037397A1 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cmv immune monitoring |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| JP5955771B2 (ja) * | 2009-10-22 | 2016-07-20 | トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 細胞ベースの抗癌組成物ならびに当該物の製造方法および使用方法 |
| SG10201501857YA (en) | 2010-03-11 | 2015-05-28 | Oncotherapy Science Inc | Hjurp Peptides And Vaccines Including The Same |
| CA2809362C (en) * | 2010-08-24 | 2020-03-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Educatn | Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| EP3536334B1 (en) | 2012-05-16 | 2021-06-23 | Stemline Therapeutics Inc. | Cancer stem cell targeted cancer vaccines |
| SG11201500429QA (en) * | 2012-07-20 | 2015-03-30 | Taiga Biotechnologies Inc | Enhanced reconstitution and autoreconstitution of the hematopoietic compartment |
| WO2014134084A2 (en) * | 2013-02-26 | 2014-09-04 | Rongfu Wang | Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy |
| RU2671897C2 (ru) * | 2013-03-01 | 2018-11-07 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Способы получения из опухоли обогащенных популяций реактивных в отношении опухоли т-клеток |
| US9704181B2 (en) * | 2014-05-06 | 2017-07-11 | International Business Machines Corporation | Real-time social group based bidding system |
| KR20190092472A (ko) | 2016-12-02 | 2019-08-07 | 타이가 바이오테크놀로지스, 인코포레이티드 | 나노입자 제제 |
| CR20190388A (es) * | 2017-01-27 | 2019-10-16 | Immatics Biotechnologies Gmbh | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer |
| MA47367B1 (fr) * | 2017-01-27 | 2023-06-28 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers |
| AR110857A1 (es) | 2017-01-27 | 2019-05-08 | Immatics Biotechnologies Gmbh | Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer |
| KR20210086612A (ko) | 2018-09-04 | 2021-07-08 | 트레오스 바이오 리미티드 | 펩타이드 백신 |
| CN113355432A (zh) * | 2021-05-12 | 2021-09-07 | 甘肃农业大学 | Bmf作为细胞凋亡标志物的应用 |
| WO2022245249A1 (ru) * | 2021-05-17 | 2022-11-24 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | Пептидные соединения для индукции апоптоза в опухолевой клетке |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| ATE280180T1 (de) | 1992-08-31 | 2004-11-15 | Ludwig Inst Cancer Res | Vom mage-3-gen abgeleitetes und von hla-a1 präsentiertes, isoliertes nonapeptid und dessen anwendungen |
| US5470955A (en) | 1993-02-02 | 1995-11-28 | Dartmouth College | Antibodies which specifically bind mcl-1 polypeptide |
| US5646008A (en) * | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
| US5700638A (en) * | 1993-08-26 | 1997-12-23 | Washington University | Cell death regulator |
| GB9320597D0 (en) | 1993-10-06 | 1993-11-24 | Proteus Molecular Design | Improvements in and realting to vaccines |
| US6096313A (en) | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US5789201A (en) * | 1996-02-23 | 1998-08-04 | Cocensys, Inc. | Genes coding for bcl-y a bcl-2 homologue |
| ATE414149T1 (de) | 1996-11-20 | 2008-11-15 | Univ Yale | Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation |
| WO1998058541A1 (en) * | 1997-06-24 | 1998-12-30 | Dana-Farber Cancer Institute, Inc. | Modulation of apoptosis |
| AU3471200A (en) * | 1999-11-16 | 2001-05-30 | Dartmouth College | Mcl-1 gene regulatory elements and a pro-apoptotic mcl-1 variant |
| WO2001044282A2 (en) | 1999-12-14 | 2001-06-21 | The Burnham Institute | Bcl-g polypeptides, encoding nucleic acids and methods of use |
| AU2001271426A1 (en) | 2000-07-17 | 2002-01-30 | Washington University | Modulation of apoptosis |
| WO2002072627A2 (en) | 2001-03-09 | 2002-09-19 | Callistogen Ag | Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| US7892559B2 (en) * | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| WO2004089980A2 (en) | 2003-04-11 | 2004-10-21 | KRæFTENS BEKæMPELSE | Therapeutic cancer vaccine |
-
2004
- 2004-11-18 JP JP2006540170A patent/JP4926714B2/ja active Active
- 2004-11-18 US US10/580,016 patent/US7842294B2/en active Active
- 2004-11-18 DE DE602004019965T patent/DE602004019965D1/de active Active
- 2004-11-18 ES ES04797460T patent/ES2323588T3/es active Active
- 2004-11-18 ES ES09154734.9T patent/ES2436429T3/es active Active
- 2004-11-18 PT PT04797460T patent/PT1691824E/pt unknown
- 2004-11-18 EP EP09154734.9A patent/EP2087904B1/en active Active
- 2004-11-18 DK DK04797460T patent/DK1691824T3/da active
- 2004-11-18 KR KR1020127016885A patent/KR101284237B1/ko active IP Right Grant
- 2004-11-18 CA CA2546794A patent/CA2546794C/en active Active
- 2004-11-18 CN CN2004800407050A patent/CN1921878B/zh active Active
- 2004-11-18 PL PL09154734T patent/PL2087904T3/pl unknown
- 2004-11-18 DK DK09154734.9T patent/DK2087904T3/da active
- 2004-11-18 MX MXPA06005738A patent/MXPA06005738A/es active IP Right Grant
- 2004-11-18 RU RU2006121466/15A patent/RU2367468C2/ru active
- 2004-11-18 EP EP04797460A patent/EP1691824B1/en active Active
- 2004-11-18 AU AU2004290866A patent/AU2004290866B2/en active Active
- 2004-11-18 AT AT04797460T patent/ATE424842T1/de active
- 2004-11-18 WO PCT/DK2004/000799 patent/WO2005049073A2/en active Application Filing
- 2004-11-18 PL PL04797460T patent/PL1691824T3/pl unknown
- 2004-11-18 KR KR1020067012186A patent/KR101216655B1/ko active IP Right Grant
- 2004-11-18 ZA ZA200604866A patent/ZA200604866B/en unknown
-
2007
- 2007-08-23 HK HK07109167.1A patent/HK1101131A1/xx unknown
-
2011
- 2011-09-12 JP JP2011198605A patent/JP5502823B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1101131A1 (en) | Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients | |
| CA2523467C (en) | Treatment of t-cell mediated diseases | |
| CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
| WO2007034489A3 (en) | Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom | |
| IL164643A (en) | Peptides, immunogenic compositions containing them and use thereof for the preparation of medicaments for the treatment of alzheimer's disease | |
| EP2182006A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2001052791A3 (en) | Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents | |
| HK1112367A1 (en) | Survivin peptide vaccine | |
| WO2006023598A3 (en) | Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer | |
| WO2003016915A8 (en) | Tumor specific oligosaccharide sequences and use thereof | |
| WO2006137938A3 (en) | Antibody fragments for protection from pathogen infection and methods of use thereof | |
| PL371278A1 (en) | Modified factor viii | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| MX2007003624A (es) | Peptidos y derivados tipo peptido ligando alterado de la hsp60 y composiciones farmaceuticas. | |
| HUP0402071A2 (hu) | Csökkentett immunogenitású, módosított leptin | |
| DK1290160T3 (da) | Humane Pellino-polypeptider | |
| EP1812035A4 (en) | PEPTIDE ANTITUMOR AGENT | |
| IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
| EP2322209A3 (en) | Tumor specific oligosaccharide epitopes and use thereof | |
| GB0004576D0 (en) | Proteins | |
| WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
| HK1150627A1 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
| WO2004031354A3 (en) | Human sarcoma-associated antigens | |
| HUP0303150A2 (hu) | Csökkentett immunogenitású, módosított keratinocita növekedési faktor (KGF) | |
| WO2005049072A3 (en) | Therapeutic cancer vaccine with fragments of trag-3 |